Gradient RP-HPLC method for the determination of Purity and Assay of Raloxifenehydrochloride in Bulk Drug
Author Affiliations
- 1Swami Vivekanand college of Pharmacy, Indore, INDIA
- 2Suresh Gyan Vihar University, Jaipur, INDIA
- 3B.M College of Pharmaceutical Sciences, Indore, INDIA
Res.J.chem.sci., Volume 1, Issue (2), Pages 9-16, May,18 (2011)
Abstract
Department of Chemistry, Krishna University, Machilipatnam, Andhra Pradesh, INDIA
References
- Boss S.M., Huster W.J., Neild J. et al., Effects of raloxifene hydrochloride on the endometrium of postmenopausal women, Am. J. Obstet. Gynecol., 177, 1458-64 (1997)
- Hardman J.G and Limbird L.E., (Eds.), Goodman and Gilman’s, The Pharmacological, Basis of Therapeutics, 10th ed., McGraw-Hill, New York, (2001)
- Smith A., Heckelman P.E., Obenchain J.R., Gallipeau J.A.R., Arecca and Budavari S., The Merck Index, 13th Ed., Merck Research Laboratories,White house station, NJ, 1452. and references cited there in. (2001)
- Delmas P.D., Bjarnason N.H., Mitlak B.H. et al. Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women, N Engl J Med.,337, 1641-7 (1997)
- Baker V.L. and Jaffe R.B., Clinical uses of antiestrogens, Obstet. Gynecol. Surv.,51, 45-59 (1996)
- Kauffman R. F., and Bryant H. U., Selective estrogen receptor modulators, Drug News Perspect.,, 531-9 (1995)
- Lim H. K., Stellingweif S., Sisenwine S. and K. W., J. Chromatogram. A,831, 227-241 (1999)
- Delmas P., Bjarnason N. H., Mitlak B. H., Ravoux A. C., Shah A. S., Huster W. J., Draper M. and Christiansen C. N., Engl. J. Med., 337,1641–1647 (1997)
- Zweigenbaum J. and Henion J., Anal. Chem., 72, 2446–2454 (2000)
- United State Pharmacopoeia, USP/ NF(2003)
- Nandini P. and Jayant W. P.,Indian Drugs, 38,591–592 (2001)
- Wang Q., Zhang H. M., Yu Z. G. and Shenyang Yaoke Daxue Xuebao, 19, 105 (2002)